T Cell-Redirecting Strategies to ‘STAb’ Tumors: Beyond CARs and Bispecific Antibodies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

T Cell-Redirecting Strategies to ‘STAb’ Tumors: Beyond CARs and Bispecific Antibodies

Published:2019-03 Issue:3 Volume:40 Page:243-257
ISSN:1471-4906
Container-title:Trends in Immunology
language:en
Short-container-title:Trends in Immunology

Author:

Blanco Belén,Compte Marta,Lykkemark Simon,Sanz Laura,Alvarez-Vallina Luis

Funder

CRIS Cancer Foundation

Health Research Fund

Carlos III Health Institute

European Regional Development

Danish Council for Independent Research – Medical Sciences

Spanish Ministry of Economy and Competitiveness

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference117 articles.

1. A believer’s overview of cancer immunosurveillance and immunotherapy;Finn;J. Immunol.,2018

2. Cancer immunoediting: from immunosurveillance to tumor escape;Dunn;Nat. Immunol.,2002

3. Breakthrough of the year 2013. Cancer immunotherapy;Couzin-Frankel;Science,2013

4. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

5. CAR T cell immunotherapy for human cancer;June;Science,2018

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells;Cellular Oncology;2024-07-15

2. Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations;Frontiers in Immunology;2024-05-08

3. Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses;OncoImmunology;2024-04-13

4. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo;Science Translational Medicine;2024-02-14

5. A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells;2024-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3